In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
Understanding the recommendation We stratified the recommendations by the levels of risk for CVD and CKD and systematically considered the balance of benefits, harms, other considerations, and practical issues for each risk group
But sun damage, barrier irritation, and simple flushing can look similar, so an in-person evaluation is the reliable way to confirm it rather than guessing from a mirror
PMC+1 Many studies also note that longer trials, larger sample sizes, and standardization are still needed to fully validate glutathiones efficacy
In research workflows, bacteriostatic water is commonly referenced as a diluent for lyophilized peptides and other RUO materials to support controlled laboratory preparation of solutions (per protocol and lab SOP)
